[breadcrumb_custom]

Buy, Sell Or Hold BioRestorative Therapies Inc (NASDAQ:BRTX) At $1.35?

In last trading session, BioRestorative Therapies Inc (NASDAQ:BRTX) saw 0.43 million shares changing hands with its beta currently measuring 62.02. Company’s recent per share price level of $1.35 trading at $0.07 or 5.47% at ring of the bell on the day assigns it a market valuation of $6.36M. That closing price of BRTX’s stock is at a discount of -428.15% from its 52-week high price of $7.13 and is indicating a premium of 11.11% from its 52-week low price of $1.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.55 million shares which gives us an average trading volume of 425.10K if we extend that period to 3-months.

BioRestorative Therapies Inc (NASDAQ:BRTX) trade information

Upright in the green during last session for gaining 5.47%, in the last five days BRTX remained trading in the red while hitting it’s week-highest on Monday, 02/05/24 when the stock touched $1.35 price level, adding 63.21% to its value on the day. BioRestorative Therapies Inc’s shares saw a change of -22.41% in year-to-date performance and have moved -51.79% in past 5-day. BioRestorative Therapies Inc (NASDAQ:BRTX) showed a performance of -21.02% in past 30-days. Number of shares sold short was 9140.0 shares which calculate 0.44 days to cover the short interests.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

BioRestorative Therapies Inc (BRTX) estimates and forecasts

This year revenue growth is estimated to rise 16.70% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $10k for the same.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 76.38% during past 5 years.

BRTX Dividends

BioRestorative Therapies Inc is more likely to be releasing its next quarterly report between March 27 and March 31 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

BioRestorative Therapies Inc (NASDAQ:BRTX)’s Major holders

Insiders are in possession of 19.47% of company’s total shares while institution are holding 15.05 percent of that, with stock having share float percentage of 18.69%. Investors also watch the number of corporate investors in a company very closely, which is 15.05% institutions for BioRestorative Therapies Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at BRTX for having 0.13 million shares of worth $0.56 million. And as of Jun 29, 2023, it was holding 14.56% of the company’s outstanding shares.

The second largest institutional holder is Wealth Alliance, which was holding about 44316.0 shares on Jun 29, 2023. The number of shares represents firm’s hold over 5.08% of outstanding shares, having a total worth of $0.2 million.

On the other hand, Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 0.12 million shares of worth $0.53 million or 13.88% of the total outstanding shares. The later fund manager was in possession of 6910.0 shares on May 30, 2023, making its stake of worth around $35932.0 in the company or a holder of 0.79% of company’s stock.

On Key

Related Posts